Riskpilot← Back to searchSign inGet full accessOne Thirty Labs ApS
APSActiveCVR 40724427Amaliegade 4, 3.Day spa, sauna and steam bath activities · NACE 9623Est. 201916 employees
Revenue 2024
DKK 123K
-119% vs 2023
EBITDA margin
-1215.1%
+9% vs 2023
Equity ratio
-37.7%
Financial strength
Net profit 2024
DKK -1,5M
+15% vs 2023
| Revenue | DKK 123K | -119% |
| EBITDA | DKK -1,5M | +9% |
| Net profit | DKK -1,5M | +15% |
| Total assets | DKK 1,5M | +21% |
| Equity | DKK -584K | +47% |
| Employees | 16 | — |
Legal name
One Thirty Labs ApS
CVR number
40724427
Legal form
Anpartsselskab
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
19. august 2019
Share capital
DKK 250.250
Employees
16 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at levere cryotherapy og andre behandlinger indenfor sundhed og wellness og dermed beslægtet virksomhed efter direktionens skøn.
Address
Amaliegade 4, 3.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -462 | 61 | 119 | -655 | 123 |
| Staff expenses | -327 | -748 | -815 | -992 | -1.614 |
| EBITDA | -789 | -687 | -696 | -1.646 | -1.492 |
| Depreciation & amort. | -92 | -178 | -169 | -101 | -125 |
| EBIT | -881 | -865 | -865 | -1.747 | -1.617 |
| Net financials | -12 | -3 | -3 | -2 | 127 |
| Profit before tax | -893 | -868 | -868 | -1.749 | -1.490 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -893 | -868 | -868 | -1.749 | -1.490 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 688 | 513 | 221 | 1.279 | 1.548 |
| Equity | -389 | -1.256 | -2.125 | -1.100 | -584 |
| Long-term debt | 515 | 0 | 0 | 262 | 1.574 |
| Short-term debt | 562 | 1.769 | 2.346 | 2.117 | 559 |
| Total debt | 1.076 | 1.769 | 2.346 | 2.379 | 2.133 |
EBITDA margin
-1215.1%
This company
15.8%
Market median
-7791% vs market
20202024
Equity ratio
-37.7%
This company
38.2%
Market median
-199% vs market
20202024
Return on equity
-148991400.0%
This company
18.4%
Market median
-809735970% vs market
20202024
Net profit margin
-1213.7%
This company
8.1%
Market median
-15084% vs market
20202024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20202024
Debt / equity
3.65×
This company
0.62×
Market median
-489% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-08-19 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TT Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
TINE HERTZ HOLDING ApS | Company | 33.3% | 33.3% | 2024 |
CAGX HOLDING ApS | Company | 15.0% | 15.0% | 2024 |
Mule Scott Struve Holdings ApS | Company | 15.0% | 15.0% | 2024 |
Bredmose Holding ApS | Company | 10.0% | 10.0% | 2023 |
Longevity Capital ApS | Company | 5.0% | 5.0% | 2024 |
Omnichannel Institute ApS | Company | 5.0% | 5.0% | 2024 |
Curran Capital ApS | Company | 5.0% | 5.0% | 2023 |
| Individual | 33.3% | 33.3% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TINE HERTZ HOLDING ApS
One Thirty Labs ApS Board members of One Thirty Labs ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tine Terese Hertz | Chief Executive Officer | 0 companies |